Y6M-20415-18152
3 vaccinations
5 coded responses
10 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 973 / OR
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Dose 1 — Moderna
-
2021-01-25
Dose 2 — Moderna
-
2021-01-28
Registered in v-safe
-
2021-01-28
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite, Dyspnoea, Feeling abnormal, Oxygen saturation decreased, Taste disorder, Unevaluable event — Feeling: Poor · Site: Pain, Swelling · Chills, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Systemic reaction (other): Shortness of breath, small drops in oxygen, brain fog, loss of appetite and change in taste, I am also recovering from recent clinical covid diagnosis, the second vaccine shot seemed to dramatically worsen my symptoms · Healthcare visit (other): I will continue to follow up with my providers.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-28
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-30
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea, Heart rate increased — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Shortness of breath; racing pulse but Im also recovering from covidMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-09
-
2021-06-10
Call successfulDoes not wish to fill out VAERS report
-
2021-10-27
Dose 3 — Moderna
-
2021-10-27
Survey response — day 0, dose 3MedDRA: Limb discomfort — Feeling: Fair · Site: PainFree text: Pressure spot or muscle in forearmMedDRA releases: 2024-11 · check-in free text available
-
2021-10-28
Survey response — days 1–6 daily, dose 3MedDRA: Decreased appetite — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Lack of appetiteMedDRA releases: 2024-11 · check-in free text available
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2021-10-31
- 2021-11-01
- 2021-11-02
-
2021-11-10
Survey response — day 14, dose 3MedDRA: Ageusia, Brain fog, COVID-19, Cough, Insomnia, Mood altered — Feeling: FairFree text: Aggravation of post-covid symptoms: loss of taste; brain fog; insomnia; mood lability; coughing, etc.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Moderna | |
| 2 | 2021-01-25 | Moderna | |
| 3 | 2021-10-27 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-28 | Successful 2021-06-10 |
Does not wish to fill out VAERS report |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Shortness of breath, small drops in oxygen, brain fog, loss of appetite and change in taste, I am also recovering from recent clinical covid diagnosis, the second vaccine shot seemed to dramatically worsen my symptoms
Healthcare visit (other): I will continue to follow up with my providers.
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Shortness of breath; racing pulse but Im also recovering from covid
Release 10 — day 0, dose 3
Systemic reaction (other): Pressure spot or muscle in forearm
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Lack of appetite
Release 10 — day 14, dose 3
Symptoms: Aggravation of post-covid symptoms: loss of taste; brain fog; insomnia; mood lability; coughing, etc.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Ageusia | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Mood altered | · | · | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
| SRO | Limb discomfort | · | · | ✓ |
| SRO | Oxygen saturation decreased | ✓ | ✓ | ✓ |
| SRO | Taste disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release